Literature DB >> 28986022

Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine.

Jill Dorsey1, Tanja Gonska2.   

Abstract

Gastrointestinal disease in Cystic Fibrosis (CF) is caused by defective chloride and bicarbonate transport in intestinal cells leading to reduced intraluminal fluidity, increased mucous viscosity and consequently development of intestinal inflammation, dysbiosis and often times dysmotility. This triad is also referred to as the "CF gut". A diagnosis is mainly based on clinical observation and treatment is often times decided empirically. This review of the literature should provide CF caregivers with some tools to identify intestinal inflammation, dysbiosis and dysmotility as possible cause for their patient's gastrointestinal complaints and provide an overview of our current approach to its management.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Bacterial overgrowth; CF intestine; Dybiosis; Dysmotility; Intestinal inflammation; Probiotics; SIBO

Mesh:

Year:  2017        PMID: 28986022     DOI: 10.1016/j.jcf.2017.07.014

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  19 in total

1.  Validity and Reliability of a Novel Multimodal Questionnaire for the Assessment of Abdominal Symptoms in People with Cystic Fibrosis (CFAbd-Score).

Authors:  Anke Jaudszus; Elisa Zeman; Tatjana Jans; Elena Pfeifer; Harold Tabori; Christin Arnold; Ruth K Michl; Michael Lorenz; Natalie Beiersdorf; Jochen G Mainz
Journal:  Patient       Date:  2019-08       Impact factor: 3.883

2.  Altered Stool Microbiota of Infants with Cystic Fibrosis Shows a Reduction in Genera Associated with Immune Programming from Birth.

Authors:  Katherine M Antosca; Diana A Chernikova; Courtney E Price; Kathryn L Ruoff; Kewei Li; Margaret F Guill; Natalie R Sontag; Hilary G Morrison; Shuyu Hao; Mitchell L Drumm; Todd A MacKenzie; Dana B Dorman; Lynn M Feenan; Molly A Williams; John Dessaint; Irene H Yuan; Brian J Aldrich; Lisa A Moulton; Lily Ting; Ana Martinez-Del Campo; Edward J Stewart; Margaret R Karagas; George A O'Toole; Juliette C Madan
Journal:  J Bacteriol       Date:  2019-07-24       Impact factor: 3.490

Review 3.  Luminal Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Samuel J Burton; Christine Hachem; James M Abraham
Journal:  Curr Gastroenterol Rep       Date:  2021-03-23

Review 4.  Neutrophil dysfunction in the pathogenesis of cystic fibrosis.

Authors:  Guoshun Wang; William M Nauseef
Journal:  Blood       Date:  2022-04-28       Impact factor: 25.476

Review 5.  Cystic fibrosis transmembrane conductance regulator-emerging regulator of cancer.

Authors:  Jieting Zhang; Yan Wang; Xiaohua Jiang; Hsiao Chang Chan
Journal:  Cell Mol Life Sci       Date:  2018-02-06       Impact factor: 9.261

Review 6.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

7.  CFTR is a negative regulator of γδ T cell IFN-γ production and antitumor immunity.

Authors:  Yuanyuan Duan; Guangqiang Li; Miaomiao Xu; Xiaofei Qi; Mingxia Deng; Xuejia Lin; Zhiwei Lei; Yi Hu; Zhenghu Jia; Quanli Yang; Guangchao Cao; Zonghua Liu; Qiong Wen; Zhenhua Li; Jie Tang; Wei Kevin Zhang; Pingbo Huang; Limin Zheng; Richard A Flavell; Jianlei Hao; Zhinan Yin
Journal:  Cell Mol Immunol       Date:  2020-07-15       Impact factor: 22.096

Review 8.  Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review.

Authors:  David Avelar Rodriguez; Paul MacDaragh Ryan; Erick Manuel Toro Monjaraz; Jaime Alfonso Ramirez Mayans; Eamonn Martin Quigley
Journal:  Front Pediatr       Date:  2019-09-04       Impact factor: 3.418

9.  Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.

Authors:  Pauline T Ikpa; Marcela Doktorova; Kelly F Meijsen; Natascha D A Nieuwenhuijze; Henkjan J Verkade; Johan W Jonker; Hugo R de Jonge; Marcel J C Bijvelds
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-08-27

Review 10.  Cystic Fibrosis Human Organs-on-a-Chip.

Authors:  Herbert Luke Ogden; Hoyeol Kim; Kathryn A Wikenheiser-Brokamp; Anjaparavanda P Naren; Kyu Shik Mun
Journal:  Micromachines (Basel)       Date:  2021-06-25       Impact factor: 2.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.